V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216924 | 20082707 | 1.73 | 107.6 | Palliative (P) | 2018-05-14 | 2018-05-15 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100350929 |
| 20216931 | 20082708 | 1.56 | 80.8 | Palliative (P) | 2018-09-26 | 2018-10-10 | HCX | 02 | N | HCX | 100485390 |
| 20216933 | 20082709 | 1.8 | 0 | Palliative (P) | null | 2019-09-19 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101866015 |
| 20216937 | 20082710 | 1.81 | 80.2 | Adjuvant (A) | null | 2019-05-12 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100202544 |
| 20216940 | 20082711 | 1.75 | 96.1 | Curative (C) | 2016-06-14 | 2016-06-22 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100238300 |
| 20216945 | 20082714 | 1.53 | 84.8 | Palliative (P) | 2018-12-19 | 2018-12-19 | LENVATINIB | 02 | N | LENVATINIB | 101490134 |
| 20216946 | 20082715 | 1.86 | 80.2 | Palliative (P) | 2016-03-29 | 2016-04-02 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101706590 |
| 20216947 | 20082716 | null | 105.5 | Curative (C) | null | 2019-09-21 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101111928 |
| 20216953 | 20082717 | 1.76 | 57 | Palliative (P) | null | 2016-12-12 | null | null | N | HCX | 101234667 |
| 20216965 | 20082721 | null | null | null | 2017-10-19 | 2017-11-23 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 101527100 |
| 20216966 | 20082722 | 1.75 | 56.9 | Palliative (P) | 2016-05-15 | 2016-05-29 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101765812 |
| 20216970 | 20082723 | null | null | null | 2019-03-20 | 2019-03-27 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + MITOMYCIN + RT | 100856677 |
| 20216972 | 20082724 | 1.74 | 72.8 | Curative (C) | null | 2017-12-17 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | HCX | 101280120 |
| 20216980 | 20082726 | null | null | null | 2018-07-20 | 2018-07-23 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101238088 |
| 20216981 | 20082727 | null | null | null | null | 2018-10-11 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100548524 |
| 20216982 | 20082728 | 1.72 | 99.4 | Neo-adjuvant (N) | 2017-12-05 | 2017-12-05 | null | null | Y | CAPECITABINE + IRINOTECAN | 101587114 |
| 20216984 | 20082729 | null | null | null | null | 2016-11-17 | null | null | null | HCX | 100724544 |
| 20216987 | 20082730 | 1.74 | 64 | Palliative (P) | 2018-01-28 | 2018-02-21 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100702430 |
| 20216993 | 20082731 | null | null | null | 2018-11-19 | 2018-11-25 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 101542811 |
| 20217002 | 20082733 | null | 81 | Palliative (P) | null | 2019-11-09 | Cape+Cisplatin+Trastuzumab Load | N | N | HCX | 101767869 |
| 20217006 | 20082734 | null | null | null | null | 2018-11-29 | null | null | null | CISPLATIN + ETOPOSIDE | 100692643 |
| 20217010 | 20082735 | 1.77 | 86 | Palliative (P) | 2016-05-25 | 2016-05-25 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101060104 |
| 20217011 | 20082736 | null | null | null | 2018-05-14 | 2018-06-04 | null | null | null | CISPLATIN + ETOPOSIDE | 100818087 |
| 20217016 | 20082737 | 1.72 | 57.8 | Neo-adjuvant (N) | null | 2018-08-20 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101257095 |
| 20217022 | 20082738 | 1.72 | 72.6 | Curative (C) | 2018-12-25 | 2019-01-03 | Cisplatin + Etoposide + RT | 02 | N | CISPLATIN + ETOPOSIDE | 101045138 |
| 20217027 | 20082739 | 1.56 | 70.7 | Palliative (P) | 2017-05-26 | 2017-05-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100315900 |
| 20217030 | 20082740 | null | null | null | 2016-02-28 | 2016-03-17 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101859214 |
| 20217032 | 20082741 | 1.81 | 87 | Palliative (P) | 2016-07-04 | 2016-07-20 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101621951 |
| 20217034 | 20082742 | 1.53 | 95.7 | Palliative (P) | null | 2019-12-07 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101086520 |
| 20217038 | 20082743 | 1.63 | 74.95 | Palliative (P) | null | 2020-08-01 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100176880 |
| 20217041 | 20082745 | null | null | null | 2020-02-04 | 2020-02-21 | Capecitabine (21 day) + Irinotecan | N | null | CAPECITABINE + IRINOTECAN | 101239860 |
| 20217045 | 20082746 | null | null | null | 2018-05-11 | 2018-05-11 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + IRINOTECAN | 101620540 |
| 20217048 | 20082747 | null | null | null | null | 2018-11-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101367374 |
| 20217051 | 20082748 | 1.75 | 80 | Palliative (P) | 2018-09-17 | 2018-09-19 | null | null | N | LENVATINIB | 100477966 |
| 20217061 | 20082749 | 1.7 | 74 | 03 | 2019-12-22 | 2019-12-30 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100785288 |
| 20217064 | 20082750 | 1.8 | 57.8 | Palliative (P) | 2018-03-22 | 2018-04-05 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | HCX | 101651907 |
| 20217065 | 20082751 | 1.8 | 73 | Palliative (P) | 2018-09-11 | 2018-09-17 | null | null | N | CISPLATIN + ETOPOSIDE | 101733217 |
| 20217066 | 20082752 | 1.71 | 94 | Adjuvant (A) | null | 2016-05-23 | null | null | null | HCX | 100789789 |
| 20217067 | 20082753 | null | null | null | null | 2017-09-28 | null | null | null | LENVATINIB | 100618570 |
| 20217068 | 20082754 | 1.63 | 74.4 | Neo-adjuvant (N) | 2017-04-20 | 2017-05-02 | null | null | null | HCX | 100156557 |
| 20217072 | 20082755 | 1.73 | 72.9 | Palliative (P) | 2018-07-19 | 2018-07-25 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100379273 |
| 20217073 | 20082756 | 1.66 | 83.9 | Palliative (P) | 2020-02-29 | 2020-03-06 | null | null | N | HCX | 100246559 |
| 20217074 | 20082757 | 1.59 | 94.8 | Palliative (P) | 2017-07-09 | 2017-07-20 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100058988 |
| 20217085 | 20082758 | 1.66 | 64 | null | null | 2019-06-03 | null | null | Y | LENVATINIB | 100263924 |
| 20217088 | 20082759 | 1.89 | 102.65 | Palliative (P) | 2016-10-19 | 2016-10-19 | HCX | N | N | HCX | 101664514 |
| 20217089 | 20082760 | 1.74 | 52.5 | Curative (C) | 2016-02-19 | 2016-03-07 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN + RT | 101870125 |
| 20217091 | 20082761 | null | null | null | 2016-05-05 | 2016-05-11 | CISPLATIN + ETOPOSIDE | N | null | CISPLATIN + ETOPOSIDE | 101589858 |
| 20217092 | 20082762 | null | 54.7 | Adjuvant (A) | 2016-09-01 | 2016-09-09 | LENVATINIB | 99 | N | LENVATINIB | 101465778 |
| 20217094 | 20082763 | null | null | null | null | 2019-10-20 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101222114 |
| 20217095 | 20082764 | null | null | null | null | 2018-05-25 | null | null | null | LENVATINIB | 101125120 |